AIDS-related Diffuse Large Cell Lymphoma: Clinical Trials

3 trials for AIDS-related Diffuse Large Cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow AIDS-related Diffuse Large Cell Lymphoma: new trials by email Literature Review of AIDS-related Diffuse Large Cell Lymphoma trials Research Report on AIDS-related Diffuse Large Cell Lymphoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma
cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate - AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma
Phase 2CompletedAIDS Malignancy Consortium72016-09-152022-10-10
Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
rituximab, etoposide, doxorubicin hydrochloride - AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Immunoblastic Large Cell Lymphoma
Phase 2CompletedNational Cancer Institute (NCI)1062003-03-012014-05-14
Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment
topotecan hydrochloride, laboratory biomarker analysis - AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma
Phase 2CompletedNational Cancer Institute (NCI)772000-04-012013-02-21

Narrower conditions

Burkitt Lymphoma (1)  ·  Dendritic Cell Sarcoma, Interdigitating (1)  ·  Lymphoma, AIDS-Related (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Medulloblastoma (1)  ·  Meningeal Carcinomatosis (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Recurrence (1)

Broader conditions

Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Lymphatic Diseases (2)  ·  Lymphoma (2)  ·  Lymphoma, B-Cell (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Central Nervous System Neoplasms (1)  ·  DNA Virus Infections (1)  ·  Disease Attributes (1)  ·  Epstein-Barr Virus Infections (1)  ·  Glioma (1)

Interventions

Cyclophosphamide (2)  ·  Doxorubicin (2)  ·  Etoposide (2)  ·  Prednisone (2)  ·  Vincristine (2)  ·  Lomustine (1)  ·  Procarbazine (1)  ·  Rituximab (1)  ·  Topotecan (1)  ·  trioctyl phosphine oxide (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  AIDS Malignancy Consortium (1)

Countries

United States (2)  ·  Kenya (1)  ·  Zimbabwe (1)

Top investigators

Joseph Sparano (1)  ·  Robert Strother (1)  ·  Susan Blaney (1)

Results publications

PMID 20023215, PMID 32107337

NIH funding

U01CA070019 (1), U01CA121947 (1), U10CA098543 (1)